Mr Spandan Silvester Athaide, Technical Lead, Central Solutions Enterprise

Read more

Panel Discussion: Navigating India Pharma Inc’s challenges and opportunities

Read more

AstraZeneca plans to invest Rs 250 crore to grow its Global Innovation and Technology Centre in India, bringing some 1,300 highly skilled roles by 2025

Read more

Alembic Pharma announces US FDA tentative approval for Ivosidenib tablets 250 mg

Read more

Submission of Nidlegy marketing authorisation application validated by EMA

Read more

GSK buys COVID, influenza vaccines from retrenching CureVac

Read more

Express Pharma July 2024

Read more

EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD: GlobalData

Read more

AGI Greenpac invests ₹230 crore to strengthen production and elevate export capabilities

Read more

Pharma funding down 57.6% in June 2024, but up YoY

Read more